ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 16 Jan 2023
Last Applicant/ Owned by
533 Airport Boulevard, Suite 400
Burlingame
CA
94010
Serial Number
90537397 filed on 20th Feb 2021
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
LENZYKINE
Pharmaceutical preparations and substances, namely, antibodies for the treatment of cancer, Immunotherapy-related toxicity, and COVID-19 Chemical, biochemical and biotechnological preparations used in industry and science, namely, antibodies and fragments of antibodies for use in the manufacture of pharmaceutical preparations
Classification Information
Class [001]
Chemical Products
Chemical, biochemical and biotechnological preparations used in industry and science, namely, antibodies and fragments of antibodies for use in the manufacture of pharmaceutical preparations
Class [005]
Pharmaceutical Products
Pharmaceutical preparations and substances, namely, antibodies for the treatment of cancer, Immunotherapy-related toxicity, and COVID-19
Mark Details
Serial Number
No 90537397
Mark Type
No Service/Collective Mark
Attorney Docket Number
No T-603131-US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 17th Jan 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 16th Jan 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 12th May 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 10th May 2022 | SOU EXTENSION 1 GRANTED |
| 10th May 2022 | SOU EXTENSION 1 FILED |
| 10th May 2022 | TEAS EXTENSION RECEIVED |
| 14th Dec 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 19th Oct 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 19th Oct 2021 | PUBLISHED FOR OPPOSITION |
| 29th Sep 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |